Recognition of congestive heart failure due to senile cardiac amyloidosis

Morie Gertz, R. A. Kyle, W. D. Edwards

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Senile cardiac amyloidosis has been considered an incidental finding at autopsy in the elderly and of little clinical importance. Autopsy studies have shown that a subset of this group have large deposits of amyloid in their ventricles. Many of these patients had congestive heart failure antemortem. Senile cardiac amyloidosis, however, is rarely diagnosed antemortem and is often confused with primary systemic amyloidosis involving the myocardium. Using endomyocardial biopsy with newly developed immunohistochemical techniques, we have been able to recognize senile cardiac amyloidosis premortem. We have found that these patients have a longer survival than patients with primary systemic amyloidosis. In addition, senile cardiac amyloidosis occurs at a younger age than autopsy studies suggest. Recognition is important because these patients should not be given treatment reserved for the therapy of primary cardiac amyloidosis. senile cardiac amyloidosis / two-dimensional echocardiography / endomyocardial biopsy.

Original languageEnglish (US)
Pages (from-to)101-106
Number of pages6
JournalBiomedicine and Pharmacotherapy
Volume43
Issue number2
DOIs
StatePublished - Jan 1 1989

Fingerprint

Amyloidosis
Heart Failure
Autopsy
Biopsy
Incidental Findings
Amyloid Plaques
Echocardiography
Myocardium
Survival
Therapeutics
Primary amyloidosis

ASJC Scopus subject areas

  • Pharmacology

Cite this

Recognition of congestive heart failure due to senile cardiac amyloidosis. / Gertz, Morie; Kyle, R. A.; Edwards, W. D.

In: Biomedicine and Pharmacotherapy, Vol. 43, No. 2, 01.01.1989, p. 101-106.

Research output: Contribution to journalArticle

@article{e82e34eebc714975923e448de81fc95b,
title = "Recognition of congestive heart failure due to senile cardiac amyloidosis",
abstract = "Senile cardiac amyloidosis has been considered an incidental finding at autopsy in the elderly and of little clinical importance. Autopsy studies have shown that a subset of this group have large deposits of amyloid in their ventricles. Many of these patients had congestive heart failure antemortem. Senile cardiac amyloidosis, however, is rarely diagnosed antemortem and is often confused with primary systemic amyloidosis involving the myocardium. Using endomyocardial biopsy with newly developed immunohistochemical techniques, we have been able to recognize senile cardiac amyloidosis premortem. We have found that these patients have a longer survival than patients with primary systemic amyloidosis. In addition, senile cardiac amyloidosis occurs at a younger age than autopsy studies suggest. Recognition is important because these patients should not be given treatment reserved for the therapy of primary cardiac amyloidosis. senile cardiac amyloidosis / two-dimensional echocardiography / endomyocardial biopsy.",
author = "Morie Gertz and Kyle, {R. A.} and Edwards, {W. D.}",
year = "1989",
month = "1",
day = "1",
doi = "10.1016/0753-3322(89)90137-6",
language = "English (US)",
volume = "43",
pages = "101--106",
journal = "Biomedicine and Pharmacotherapy",
issn = "0753-3322",
publisher = "Elsevier Masson",
number = "2",

}

TY - JOUR

T1 - Recognition of congestive heart failure due to senile cardiac amyloidosis

AU - Gertz, Morie

AU - Kyle, R. A.

AU - Edwards, W. D.

PY - 1989/1/1

Y1 - 1989/1/1

N2 - Senile cardiac amyloidosis has been considered an incidental finding at autopsy in the elderly and of little clinical importance. Autopsy studies have shown that a subset of this group have large deposits of amyloid in their ventricles. Many of these patients had congestive heart failure antemortem. Senile cardiac amyloidosis, however, is rarely diagnosed antemortem and is often confused with primary systemic amyloidosis involving the myocardium. Using endomyocardial biopsy with newly developed immunohistochemical techniques, we have been able to recognize senile cardiac amyloidosis premortem. We have found that these patients have a longer survival than patients with primary systemic amyloidosis. In addition, senile cardiac amyloidosis occurs at a younger age than autopsy studies suggest. Recognition is important because these patients should not be given treatment reserved for the therapy of primary cardiac amyloidosis. senile cardiac amyloidosis / two-dimensional echocardiography / endomyocardial biopsy.

AB - Senile cardiac amyloidosis has been considered an incidental finding at autopsy in the elderly and of little clinical importance. Autopsy studies have shown that a subset of this group have large deposits of amyloid in their ventricles. Many of these patients had congestive heart failure antemortem. Senile cardiac amyloidosis, however, is rarely diagnosed antemortem and is often confused with primary systemic amyloidosis involving the myocardium. Using endomyocardial biopsy with newly developed immunohistochemical techniques, we have been able to recognize senile cardiac amyloidosis premortem. We have found that these patients have a longer survival than patients with primary systemic amyloidosis. In addition, senile cardiac amyloidosis occurs at a younger age than autopsy studies suggest. Recognition is important because these patients should not be given treatment reserved for the therapy of primary cardiac amyloidosis. senile cardiac amyloidosis / two-dimensional echocardiography / endomyocardial biopsy.

UR - http://www.scopus.com/inward/record.url?scp=0024539562&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024539562&partnerID=8YFLogxK

U2 - 10.1016/0753-3322(89)90137-6

DO - 10.1016/0753-3322(89)90137-6

M3 - Article

VL - 43

SP - 101

EP - 106

JO - Biomedicine and Pharmacotherapy

JF - Biomedicine and Pharmacotherapy

SN - 0753-3322

IS - 2

ER -